IN2012DE00912A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00912A
IN2012DE00912A IN912DE2012A IN2012DE00912A IN 2012DE00912 A IN2012DE00912 A IN 2012DE00912A IN 912DE2012 A IN912DE2012 A IN 912DE2012A IN 2012DE00912 A IN2012DE00912 A IN 2012DE00912A
Authority
IN
India
Prior art keywords
stable
antioxidants
free
amino acids
chelating agents
Prior art date
Application number
Other languages
English (en)
Inventor
Dhiraj Khattar
Rajesh Khanna
Mukti Yuadav
Krishanu Burman
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Priority to US14/387,670 priority Critical patent/US20150073000A1/en
Priority to PCT/IB2013/052356 priority patent/WO2013144814A1/fr
Priority to IN912DE2012 priority patent/IN2012DE00912A/en
Publication of IN2012DE00912A publication Critical patent/IN2012DE00912A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN912DE2012 2012-03-27 2013-03-25 IN2012DE00912A (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/387,670 US20150073000A1 (en) 2012-03-27 2013-03-25 Stable ready-to-use pharmaceutical composition of pemetrexed
PCT/IB2013/052356 WO2013144814A1 (fr) 2012-03-27 2013-03-25 Composition pharmaceutique prête-à-l'emploi stable de pemetrexed
IN912DE2012 IN2012DE00912A (fr) 2012-03-27 2013-03-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN912DE2012 IN2012DE00912A (fr) 2012-03-27 2013-03-25

Publications (1)

Publication Number Publication Date
IN2012DE00912A true IN2012DE00912A (fr) 2015-09-11

Family

ID=48095972

Family Applications (1)

Application Number Title Priority Date Filing Date
IN912DE2012 IN2012DE00912A (fr) 2012-03-27 2013-03-25

Country Status (3)

Country Link
US (1) US20150073000A1 (fr)
IN (1) IN2012DE00912A (fr)
WO (1) WO2013144814A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3287123T (pt) 2011-03-04 2020-05-22 Gruenenthal Gmbh Formulação farmacêutica aquosa de tapentadol para administração oral
KR101703980B1 (ko) * 2013-12-30 2017-02-08 주식회사 삼양바이오팜 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
EP3206666B1 (fr) 2014-10-16 2019-12-11 Synthon B.V. Compositions pharmaceutiques liquides contenant du pémétrexed
EP4011377A1 (fr) * 2015-02-13 2022-06-15 Sun Pharmaceutical Industries Ltd Forme posologique de perfusion intraveineuse
US20170340639A1 (en) 2015-03-26 2017-11-30 Ftf Pharma Private Limited Pharmaceutical composition of pemetrexed
PL3273953T3 (pl) 2015-03-27 2019-07-31 Grünenthal GmbH Stabilny preparat do pozajelitowego podawania tapentadolu
JP6768786B2 (ja) * 2015-07-30 2020-10-14 エクスプレッション、パソロジー、インコーポレイテッドＥｘｐｒｅｓｓｉｏｎ Ｐａｔｈｏｌｏｇｙ， Ｉｎｃ． 最適な癌療法のためのＦＲ−αおよびＧＡＲＴタンパク質の定量
KR20180132643A (ko) * 2016-02-19 2018-12-12 이글 파마슈티컬즈 인코포레이티드 페메트렉시드 제제
US20170239250A1 (en) 2016-02-19 2017-08-24 Eagle Pharmaceuticals, Inc. Pemetrexed formulations
WO2018002956A1 (fr) * 2016-06-27 2018-01-04 Sun Pharmaceutical Industries Ltd. Solution stable injectable de pémétrexed
MX2019003257A (es) 2016-09-23 2019-06-10 Gruenenthal Gmbh Formulacion estable para la administracion parenteral de tapentadol.
AU2018349426B2 (en) 2017-10-10 2024-01-18 Sun Pharmaceutical Industries Limited Intravenous infusion dosage form for pemetrexed

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0162654B1 (ko) 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
CN100334293C (zh) 1999-03-16 2007-08-29 花王株式会社 液体除臭剂
US6686365B2 (en) 2000-02-04 2004-02-03 Eli Lilly And Company Pharmaceutical composition
WO2010030598A2 (fr) * 2008-09-11 2010-03-18 Dr. Reddy's Laboratories Limited Formulations pharmaceutiques comprenant du pemetrexed
JP2013540104A (ja) 2010-07-28 2013-10-31 イーグル・ファーマシューティカルズ・インコーポレーテッド 延長された保存安定性を有するペメトレキセドを含有する医薬組成物
KR101069128B1 (ko) * 2011-03-10 2011-09-30 건일제약 주식회사 페메트렉시드 또는 그의 염을 포함하는 항산화제-비함유 주사용 용액 형태의 약학적 제제의 제조방법

Also Published As

Publication number Publication date
US20150073000A1 (en) 2015-03-12
WO2013144814A1 (fr) 2013-10-03

Similar Documents

Publication Publication Date Title
IN2012DE00912A (fr)
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
MX2018012166A (es) Dosificacion oral de compuestos peptido similar al glaucon-1 (glp-1).
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX2015010971A (es) Derivado novedoso de pirazol.
IN2014DN10386A (fr)
MY163083A (en) Solid forms of a pharmaceutically active substance
MX2020003096A (es) Formulaciones farmaceuticas de un inhibidor de hidroxilasa de hif.
IN2014DN10670A (fr)
MX362879B (es) Usos novedosos.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
IN2014MN02236A (fr)
IN2013MU03641A (fr)
PH12016500497A1 (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
PH12015501386A1 (en) Tricyclic compounds
MX2015012318A (es) Formas de estado solido de un derivado de quinazolina y su uso como un inhibidor de braf.
MY195384A (en) Two-Component Composition
PH12015502706A1 (en) Oral formulation for the treatment of cardiovascular diseases
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
MX2015016490A (es) Esteres sulfatados de acidos oligohidroxicarboxilicos, y uso de los mismos.
IN2015DN02109A (fr)
EP3132797A4 (fr) Utilisation d'une composition renfermant un chélate ferreux d'acides aminés dans la préparation d'un médicament pour améliorer le diabète
IN2013MU03317A (fr)
IN2013MU03838A (fr)